Cubist Systematic Strategies, LLC 10x Genomics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 223,950 shares of TXG stock, worth $3.16 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

223,950

Holding current value

$3.16 Million

% of portfolio

0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.71 - $23.49 $3.52 Million - $5.26 Million	223,950 New	223,950 $5.06 Million
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $8.73 Million - $13.1 Million	241,958 Added 196.13%	365,322 $13.7 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $2.05 Million - $3.45 Million	59,866 Added 94.28%	123,364 $6.9 Million
Q3 2023 Nov 14, 2023	SELL	$40.86 - $62.98 $4.3 Million - $6.64 Million	-105,351 Reduced 62.39%	63,498 $2.62 Million
Q2 2023 Aug 14, 2023	BUY	$50.96 - $58.72 $8.6 Million - $9.91 Million	168,849 New	168,849 $9.43 Million
Q4 2022 Feb 14, 2023	SELL	$24.4 - $41.3 $1.35 Million - $2.29 Million	-55,399 Reduced 24.04%	175,048 $6.38 Million
Q3 2022 Nov 14, 2022	BUY	$28.48 - $52.59 $1.51 Million - $2.78 Million	52,941 Added 29.82%	230,447 $6.56 Million
Q2 2022 Aug 15, 2022	BUY	$36.95 - $82.41 $1.81 Million - $4.03 Million	48,890 Added 38.01%	177,506 $8.03 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $7.02 Million - $18.4 Million	126,018 Added 4850.58%	128,616 $9.78 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $400,828 - $541,927	-2,968 Reduced 53.32%	2,598 $387,000
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $1.47 Million - $1.94 Million	-10,114 Reduced 64.5%	5,566 $810,000
Q2 2021 Aug 16, 2021	BUY	$134.22 - $202.37 $2.09 Million - $3.16 Million	15,607 Added 21379.45%	15,680 $3.07 Million
Q1 2021 May 17, 2021	SELL	$140.25 - $196.86 $3.4 Million - $4.77 Million	-24,228 Reduced 99.7%	73 $13,000
Q4 2020 Feb 16, 2021	SELL	$126.47 - $163.7 $1.78 Million - $2.31 Million	-14,102 Reduced 36.72%	24,301 $3.44 Million
Q3 2020 Nov 16, 2020	BUY	$87.44 - $125.0 $2.5 Million - $3.58 Million	28,637 Added 293.23%	38,403 $4.79 Million
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $565,507 - $864,967	9,685 Added 11956.79%	9,766 $872,000
Q1 2020 May 15, 2020	SELL	$51.57 - $106.62 $164,147 - $339,371	-3,183 Reduced 97.52%	81 $5,000
Q4 2019 Feb 14, 2020	BUY	$46.07 - $79.54 $96,148 - $165,999	2,087 Added 177.32%	3,264 $249,000
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $58,838 - $72,974	1,177 New	1,177 $59,000

Others Institutions Holding TXG

# of Institutions

289

Shares Held

94.7M

Call Options Held

195K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.34B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC 10x Genomics, Inc. Transaction History